Development of a hyperpolarized 129Xe system on 3T for the rat lungs.
MRI (magnetic resonance imaging) with 129Xe has gained much attention as a diagnostic methodology because of its affinity for lipids and possible polarization. The quantitative estimation of net detectability and stability of hyperpolarized 129Xe in the dissolved phase in vivo is valuable to the development of clinical applications. The goal of this study was to develop a stable hyperpolarized 129Xe experimental 3T system to statistically analyze the dissolved-phase 129Xe signal in the rat lungs. The polarization of 129Xe with buffer gases at the optical pumping cell was measured under adiabatic fast passage against the temperature of an oven and laser absorption at the cell. The gases were insufflated into the lungs of Sprague-Dawley rats (n = 15, 400-550 g) through an endotracheal tube under spontaneous respiration. Frequency-selective spectroscopy was performed for the gas phase and dissolved phase. We analyzed the 129Xe signal in the dissolved phase to measure the chemical shift, T2*, delay and its ratio in a rat lungs on 3T. The polarizer was able to produce polarized gas (1.1+/-0.47%, 120 cm3) hundreds of times with the laser absorption ratio (25%) kept constant at the cell. The optimal buffer gas ratio of 25-50% rendered the maximum signal in the dissolved phase. Two dominant peaks of 211.8+/-0.9 and 201.1+/-0.6 ppm were observed with a delay of 0.4+/-0.9 and 0.9+/-1.0 s from the gas phase spectra. The ratios of their average signal to that of the gas phase were 5.6+/-5.2% and 4.4+/-4.7%, respectively. The T2* of the air space in the lungs was 2.5+/-0.5 ms, which was 3.8 times shorter than that in a syringe. We developed a hyperpolarized 129Xe experimental system using a 3T MRI scanner that yields sufficient volume and polarization and quantitatively analyzed the dissolved-phase 129Xe signal in the rat lungs.
Sato
Hiroshi
H
Department of Investigative Radiology, Research Institute of National Cardiovascular Center, Suita. Osaka, Japan. hiroshi.sato@gemsa.med.ge.com
Enmi
Jun-Ichiro
J
Hayashi
Takuya
T
Takei
Naoyuki
N
Iwadate
Yuji
Y
Abe
Sumiko
S
Teramoto
Noboru
N
Kawachi
Naoki
N
Hattori
Mineyuki
M
Watabe
Hiroshi
H
Sawada
Tohru
T
Uchiyama
Katsumi
K
Tsukamoto
Tetsuji
T
Nagasawa
Kiyoshi
K
Iida
Hidehiro
H
D000280:Administration, Inhalation; D000818:Animals; D007089:Image Enhancement; D008168:Lung / Q000033:anatomy & histology*; D008279:Magnetic Resonance Imaging / Q000379:methods*; D005741:Noble Gases / Q000008:administration & dosage / Q000493:pharmacokinetics; D051381:Rats; D017207:Rats, Sprague-Dawley; D014979:Xenon Isotopes / Q000008:administration & dosage / Q000493:pharmacokinetics
D005741:Noble Gases; D014979:Xenon Isotopes